Pharmacology, Toxicology and Pharmaceutical Science
Acute Coronary Syndrome
5%
Adverse Event
25%
Albuminuria
18%
All Cause Mortality
5%
Amiloride
35%
Amlodipine
16%
Angiotensin Receptor Antagonist
9%
Ankle Edema
16%
Antihypertensive Agent
16%
Cardiovascular Risk
5%
Cerebrovascular Accident
11%
Congestive Heart Failure
5%
Contrast Medium
16%
Creatinine
13%
Cytokine
18%
Diabetes Mellitus
7%
Diltiazem
8%
Dipeptidyl Carboxypeptidase Inhibitor
8%
Diuretic Agent
10%
Drug Action
10%
Edema
8%
Epithelial Sodium Channel
33%
Fibulin
16%
Foot Edema
8%
Insulin Dependent Diabetes Mellitus
5%
Interferon
16%
Interleukin 10
6%
Interleukin 17
23%
Interleukin 6
33%
Intervention Trial
16%
Lacidipine
8%
Lercanidipine
8%
Microalbuminuria
6%
Mineralocorticoid Receptor
18%
Non Insulin Dependent Diabetes Mellitus
100%
Placebo
19%
Plasmin
16%
Plasminogen
6%
Prospective Study
16%
Radioisotope
16%
Randomized Clinical Trial
16%
Receptor Blocking Agent
18%
Resistant Hypertension
69%
Side Effect
8%
Sodium Channel
5%
Spironolactone
66%
Tumor Necrosis Factor
20%
Verapamil
8%
Biochemistry, Genetics and Molecular Biology
Aldosterone
16%
Aldosterone Blood Level
6%
Arterial Pressure
5%
Blood Plasma
32%
Blood Pressure
52%
Body Mass
16%
Clinical Trial
7%
Creatinine
20%
Epithelial Sodium Channel
40%
Estropipate
6%
Fibrinolysin
16%
Immunoblotting
5%
Intervention Trial
16%
Low Drug Dose
16%
Metabolite
16%
Mineralocorticoid Receptor
11%
Plasmin
16%
Protease
5%
Proteomics
16%
Randomized Clinical Trial
19%
Spironolactone
63%
Systolic Blood Pressure
20%
Medicine and Dentistry
Aortic Stenosis
16%
Calcium Metabolism
8%
Chronic Kidney Disease
13%
Creatinine
6%
Diagnosis
5%
Echocardiography
8%
End Stage Renal Disease
16%
Epithelial Sodium Channel
16%
Extracorporeal Membrane Oxygenation
16%
Fibrinolysin
16%
Heart Left Ventricle Ejection Fraction
16%
Heart Left Ventricle Outflow Tract Obstruction
16%
Hemodialysis
16%
Hemodynamic
16%
In Vitro
16%
Low Drug Dose
5%
Magnetic Resonance Imaging
11%
Microalbuminuria
6%
Obstruction
5%
Patient Compliance
5%
Patient with Type 2 Diabetes
16%
Pelvis
16%
Phosphate Metabolism
8%
Plasminogen
6%
Resistant Hypertension
16%
Resuscitation
16%
Tertiary Hyperparathyroidism
5%
Urinary System
8%
